Femasys Inc. (FEMY) vs Intelligent Bio Solutions Inc. (INBS)
A side-by-side comparison of Femasys Inc. and Intelligent Bio Solutions Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FEMY
Femasys Inc.
$2.04HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
INBS
Intelligent Bio Solutions Inc.
$1.58HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
Total return — FEMY vs INBS
growth of $100 · dividends reinvested · last 5yFEMY -99.2% (-61.5%/yr)INBS -100.0% (-82.6%/yr)FEMY compounded faster over this window
Log scale — wide-divergence pair
FEMY INBS
FEMY vs INBS: by the numbers
- •FEMY is the larger company ($6M vs $5M market cap).
- •Both run net losses; INBS's is the smaller (-294.91% vs -534.27% net margin).
- •INBS grew revenue faster over the past five years (19.95% vs 12.97% CAGR).
Metrics side by side
Valuation
| Metric | FEMY | INBS |
|---|---|---|
| P/S ratio | 2.68 | 1.24 |
| P/B ratio | 1.53 | 0.95 |
Profitability
| Metric | FEMY | INBS |
|---|---|---|
| Gross margin | 61.96% | 48.63% |
| Operating margin | -763.90% | -305.03% |
| Net margin | -534.27% | -294.91% |
| ROE | -304.78% | -225.57% |
| ROIC | -209.05% | -179.58% |
Growth (annualized)
| Metric | FEMY | INBS |
|---|---|---|
| Revenue CAGR (5Y) | 12.97% | 19.95% |
| Total return CAGR (5Y) | -57.27% | -80.26% |
Frequently asked
- Which has grown faster, FEMY or INBS?
- Over the past five years, INBS grew revenue faster — FEMY at a 12.97% CAGR versus INBS at 19.95%.
- How have FEMY and INBS total returns compared?
- Over the past 5 years, FEMY delivered -57.27% and INBS delivered -80.26% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Femasys ROEIntelligent Bio Solutions ROEFemasys operating marginIntelligent Bio Solutions operating marginFemasys revenue growthIntelligent Bio Solutions revenue growthFemasys free cash flowIntelligent Bio Solutions free cash flow
Femasys & Intelligent Bio Solutions appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.